Therapeutic potency of estrophanthin in pseudo-pregnancy (hydrometra) of goats
https://doi.org/10.26897/0021-342X-2023-1-104-113
Abstract
The aim of the study was to carry out a comparative evaluation of the therapeutic potency of Estrophantine®, a drug of the highly active synthetic analog of prostaglandin F2 alpha (PgF2α) cloprostenol, when goats with hydrometer were twice injected intramuscularly with a 10-day interval in a dose of 0.5 and 1.0 ml, respectively. The objects of the study were breeding goats of breeding age (n=6) and lactating goats (n=37) of the Zaanen breed diagnosed with false pregnancy during screening ultrasound examination. The animals were divided into two experimental groups according to the analogy principle. The animals in the first experimental group (n=21) were twice injected intramuscularly with a 10-day interval in the dose of 0.5 ml (125 μg cloprostenol), and those in the second group (n=22) were also twice injected intramuscularly with with a 10-day interval, but in the dose of 1.0 ml (250 μg cloprostenol). The results of the study showed high therapeutic potency of Estrophantine® when goats with hydrometer were twice injected intramuscularly with with a 10-day interval in the dose of 1.0 ml. After the first dose of the preparation complete expulsion of intrauterine fluid was noted in 81.82% of goats with hydrometer. The effectiveness of the method for a complete course of treatment was 100% according to the percentage of cured animals, and 86.36% and 77.27% according to the frequency of renewal of sexual cycling and pregnancy rate, respectively. None of the 5 (22.73%) goats found to be infertile registered a relapse of hydrometra after treatment.
An Estrofantin® dose of 0.5 ml (125 μg cloprostenol) was found to be inadequate for treatment of goats with hydrometra. After the first dose, complete expulsion of intrauterine fluid was noted in only 52.38% of animals. When Estrophantine® is used at the lowest therapeutic dose (125 μg cloprostenol) the effectiveness of prostaglandin therapy over a full course of treatment is reduced by 4.76% in the proportion of cured animals, by 10.17% in the renewal of sexual cycling and by 15.37% in pregnancy rate. At the same time, the risk of relapse is 5%.
About the Authors
K. O. ShatskyRussian Federation
Kirill O. Shatsky, post-graduate student of the Department of Veterinary Medicine
49 Timiryazevskaya Str., Moscow, 127434
phone: (499) 977–17–82
G. P. Dyulger
Russian Federation
Georgiy P. Dyulger, DSc (Vet), Head of the Department of Veterinary Medicine
49 Timiryazevskaya Str., Moscow, 127434
phone: (499) 977–17–82
References
1. Dyulger G.P., Khramtsov V.V., Sibileva Yu.G., Kemeshov Zh.O., I.Ye. Yushchenko, Dyulger P.G., Sedletskaya E.S. Lekarstvennye sredstva, primenyaemye v veterinarnom akusherstve, ginekologii, andrologii i biotekhnike razmnozheniya zhivotnykh. Spravochnoe posobie [Medicinal products used in veterinary obstetrics, gynecology, andrology and biotechnics of animal reproduction. Reference manual]. SPb.: Izd-vo “Lan’”, 2016: 272. (In Rus.)
2. Shatsky K., Dyulger G., Leont’ev L. et al. Psevdoberemennost’ koz [Pseudo-pregnancy of goats]. Veterinariya sel’skokhozyaystvennykh zhivotnykh. 2021; 1: 22–27. (In Rus.)
3. Almubarak A.M., Abdelghafar R.M., Badawi M.E. Hydrometra in a Goat – Diagnosis, Treatment and Subsequent Fertility. Intern. J. Livestock Res. 2016; 6(4): 114–118. DOI:10.5455/ijlr.20160412112841
4. Barna T., Apić J., Bugarski D. et al. Incidence of hydrometra in goats and therapeutic effects. Arh. Veter. Med. 2017; 10(1): 13–24.
5. Batista M.M., Medina J., Calero R. et al. Incidence and treatment of hydrometra in Canary Island goats. Vet. Rec. 2001; 149: 329–330.
6. Bisla A., Kumar B., Yadav D. et al. Ultrasonographic Diagnosis and Clinical Management of Pseudopregnancy in Goats. Theriogenology Insight. 2019; 9(1): 13–18. DOI: 10.30954/2277–3371.01.2019
7. Duquesnel R., Parisot D., Pirot G. et al. La pseudogestation chez la chèvre [Pseudogestation in goats]. Ann. Zootech. 1992; 41: 407–415. (In French)
8. Dyulger G.P., Stekolnikov A.A., Shatsky K.O. et al. Pathophysiological aspects of goat false pregnancy (hydrometra) and modern methods of its diagnosis and therapy. Bulletin of National Academy of Sciences of the Republic of Kazakhstan. 2020; 1: 1–9.
9. Farliana M.D.N., Yimer N. Pseudopregnancy in a Doe and its Hormonal Therapy. Intern. J. Livestock Res. 2016; 6(6): 90–95. DOI:10.5455/ijlr.20160621011943
10. Hesselink J.W. Incidence of hydrometra in dairy goats. Vet. Rec. 1993; 132: 110–112.
11. Hesselink J.W., Elvin L. Pedigree analysis in a herd of dairy goats with respect to the incidence of hydrometra. Vet. Quart. 1996; 18: 24–25.
12. Kornalijnslijper J.E., Bevers M.M., Van Oord H.A., Taverne M.A.M. Induction of hydrometra in goats by means of immunization against prostaglandin F2α. Anim. Reprod. Sci. 1997; 46: 109–122.
13. Lopes Junior E.S., Cruz J.F., Teixeira D.I. et al. Pseudopregnancy in Saanen goats (Capra hircus) raised in Northeast Brazil. / Vet. Res. Comm. 2004; 28: 119–125.
14. Maia A.L.R.S., Brandaoa F.Z., Souza-Fabjana J.M.G. et al. Hydrometra in dairy goats: Ultrasonic variables and therapeutic protocols evaluated during the reproductive season. Anim. Reprod. Sci. 2018; 197: 203–211.
15. Matthews J. Diseases of goat. 4th Edition. Valey Blackwell, 2016: 4–5.
16. Moraes E.P.B.X., M. Santos, I. Arruda et al. Hydrometra and mucometra in goats diagnosed by ultrasound and treated with PGF2α. Med. Vet. 2007; 1: 33–39.
17. Pieteres M.C., Taverne M.A. Hydrometra in goats: Diagnosis with real-time ultrasound and treatment with prostaglandins or oxytocin. Theriogenology. 1986; 26: 813–821.
18. Reddy K., Arunakumari G., Reddy A. et al. Efficacy of Cloprostenol Therapy in Hydrometra Goats. Ind. J. Anim. Reprod. 2014; 35(1): 39–41.
19. Salles M., Araújo A., da Rocha D.R., Albuquerque I.A. Incidencia de pseudogestação em cabras leiteiras criadas em clima tropical [Incidence of pseudogestation in dairy goats reared in a tropical climate]. Zootec. 2008: 3. (In Portug.)
20. Souza J., Maia A., Brandao F. et al. Hormonal treatment of dairy goats affected by hydrometra associated or not with ovarian follicular cyst. Small Ruminant Res. 2013. 111: 104–109.
21. Taverne M.A.M., Hesselink J.W., Bevers M.M. et al. Aetiology and Endocrinology of Pseudopregnancy in the Goat. Reprod. Dom. Anim. 1995; 30: 228–230.
22. Taverne M.A.M., Bevers M.M., Hesselink J.W. et al. Evidence for a dominant role of prolactin in the luteotrophic complex of pseudopregnant goats. Anim. Reprod. Sci. 1994; 36: 253–260.
23. Taverne M.A.M., Lavoir M.C., Bevers M.M. et al. Peripheral plasma prolactin and progesterone levels in pseudopregnant goats during bromocrytine treatment. Theriogenology. 1988; 30: 777–778.
24. Wittek T., Erices J., Eelze K. Histology of the endometrium, clinical–chemical parameters of the uterine fluid and blood plasma concentrations of progesterone, estradiol-17 β and prolactin during hydrometra in goats. Small Rum. Res. 1998; 30(2): 105–112.
25. Wittek T., Richter A., Erices J., Elze K. Incidence, diagnosis, therapy and subsequent fertility in goats with hydrometra. Tierarztl. Prax. 1997; 25: 576–582.
Review
For citations:
Shatsky K.O., Dyulger G.P. Therapeutic potency of estrophanthin in pseudo-pregnancy (hydrometra) of goats. IZVESTIYA OF TIMIRYAZEV AGRICULTURAL ACADEMY. 2023;(1):104-113. (In Russ.) https://doi.org/10.26897/0021-342X-2023-1-104-113